There is accumulating evidence that leptin has a pleiotropic role in hematopoiesis, immune response, fibrogenesis, and hepatocarcinogenesis. We investigated the expression of leptin and leptin receptor (OB-R) at the protein level by flow cytometry and also quantified by real-time reverse transcriptase–polymerase chain reaction (RT-PCR) the two major leptin receptor isoforms (OB-RI, OB-Rs) in peripheral blood mononuclear cells (PBMCs) of patients with hepatitis B (HBV; n = 31), hepatitis C (HCV; n = 34), and nonviral liver disease (n = 25), and healthy controls (n = 36), as well as in liver tissues of HBV (n = 8), HCV (n = 7), and healthy individuals (n = 6). Serum leptin levels were measured in all participants (N = 126). We observed significantly lower OB-RI and OB-Rs mRNA levels in PBMCs of HBV and HCV patients compared with healthy controls and nonviral liver disease patients (P < 0.05). Flow cytometry analysis confirmed the real-time RT-PCR results. Expression of leptin and OB-RI was significantly increased in viral hepatitis liver tissues compared with healthy tissues (P < 0.01). OB-RI mRNA levels were not associated with hepatitis patients' clinical status (inactive, chronic hepatitis, or cirrhosis). We also found decreased serum leptin in HBV and HCV patients compared with healthy individuals and the nonviral liver disease group. Leptin was expressed in 3 of 34 HCV (8.8%) and 19 of 25 (76%) nonviral liver disease patients. Moreover, expression of OB-RI and OB-Rs were associated when all individuals were grouped together (r = 0.78, P < 0.001). In conclusion, our findings may suggest the involvement of the leptin system in the immunopathology of chronic viral hepatitis.
La CavaA, MatareseG.The weight of leptin in immunity. Nat Rev Immunol4: 371–379, 2004.
2.
FriedmanJM, HalaasJL. Leptin and the regulation of body weight in mammals. Nature395: 763–770, 1998.
3.
OteroM, LagoR, LagoF, CasanuevaFF, DieguezC, Gomez-ReinoJJ, GualilloO.Leptin, from fat to inflammation: old questions and new insights. FEBS Lett579: 295–301, 2005.
FlierJS. Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci U S A94: 4242–4245, 1997.
6.
ZhangY, WilseyJT, FraseCD, MathenyMM, BenderBS, ZolotukhinS, ScarpacePJ. Peripheral but not central leptin prevents the immunosuppression associated with hypoleptinemia in rats. J Endocrinol174: 455–461, 2002.
7.
La CavaA, AlviggiC, MatareseG.Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med82: 4–11, 2004.
8.
MatareseG, MoschosS, MantrososCS. Leptin in immunology. J Immunol174: 3137–3142, 2005.
9.
MargeticS, GarrelaC, PeggGG, HillRA. Leptin: a review of its peripheral actions and interactions. Int J Obes26: 1407–1433, 2002.
10.
BjorbaekC, UotaniS, da SilvaB, FlierJS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem272: 32686–32695, 1997.
11.
YamashitaT, MurakamiT, OtaniS, KuwajimaM, ShimaK.Leptin receptor signal transduction: OBRa and OBRb of fa type. Biochem Biophys Res Commun246: 752–759, 1998.
12.
MurakamiT, YamashitaT, IidaM, KuwajimaM.A short form of leptin receptor performs signal transduction. Biochem Biophys Res Commun231: 26–29, 1997.
13.
TsiotraCP, PappaV, RaptisSA, TsigosC.Expression of the long and short leptin isoforms in peripheral blood mononuclear cells: implications for leptin's actions. Metabolism49: 1537–1541, 2000.
14.
LordGM, MatareseG, HowardJK, BakerRJ, BloomSR, LechlerRI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature394: 897–901, 1998.
15.
OzataM, OzdemirIC, LicinioJ.Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab84: 3686–3695, 1999.
16.
GainsfordT, WilsonTA, MetcalfD, HandmanE, McFarlaneC, NgA, NicolaNA, AlexanderWS, HiltonDJ. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A93: 14564–14568, 1996.
17.
Santos-AlvarezJ, GobemaR, Sánchez-MargaletV.Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol194: 6–11, 1999.
Martin-RomeroC, Santos-AlvarezJ, GobemaR, Sanchez-MargaletV.Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol199: 15–24, 2000.
20.
Sanchez-MargaletV, Martin-RomeroC, Santos-AlvarezJ, GobemaR, NajibS, Gonzalez-YanesC.Role of leptin as an immunomodulator of blood mononuclear cells. Clin Exp Immunol133: 11–18, 2003.
21.
Sanchez-PozoC, Rodriguez-BanoJ, Dominguez-CastellanoA, MuniainMA, GobemaR, Sanchez-MargaletV.Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients. Clin Exp Immunol134: 464–469, 2003.
22.
KozielMJ. Cytokines in viral hepatitis. Semin Liver Dis19: 157–169, 1999.
23.
SchumannJ, TiegsG.Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. Toxicology138: 103–126, 1999.
24.
SennelloJA, FayadR, MorrisAM, EckelRH, AsilmazE, MontezJ, FriedmanJM, DinarelloCA, and FantuzziG.Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology146: 2157–2164, 2005.
25.
FantuzziG, FaggioniR.Leptin in the regulation of immunity, inflammation and hematopoiesis. J Leukoc Biol68: 437–446, 2000.
RigopoulouEI, DaviesET, ParesA, ZachouK, LiaskosC, BogdanosD-P, RodesJ, DalekosGN, VerganiD.Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut54: 528–532, 2005.
33.
ZografosTA, RigopoulouE, LiaskosC, TogousidisE, ZachouK, GatselisN, GermenisA, DalekosGN. Alterations of leptin levels during IFN-alpha treatment in patients with chronic viral hepatitis B and C: evidence of an IFN-alpha-mediated suppression of leptin production. J Hepatol44: 848–855, 2006.
34.
OteroM, LagoR, LagoF, ReinoJJ, GualilloO.Signaling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther7:R581–R591, 2005.
35.
MehebikN, JaubertAM, SabouraultD, GiudicelliY, RibiereC.Leptin-induced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation. Am J Physiol Cell Physiol289:C379–C387, 2005.
36.
SogueroC, JooM, Chianese-BullockKA, NguyenDT, TungK, HahnYS. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol76: 9345–9354, 2002.
37.
NakamuraK, YuhK, SugyoS, ShijoH, KimuraN, OkumuraM.Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology111: 156–164, 1996.
38.
TayaN, TorimotoY, ShindoM, HiraiK, HasebeC, KohgoY.Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br J Haematol110: 89–97, 2000.
39.
TestaR, FranceschiniR, GianniniE, CataldiA, BottaF, FasoliA, TenerelliP, RolandiE, BarrecaT.Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol33: 33–37, 2000.
40.
IchikiY, AokiC, BowlusC, ShimodaS, IshibahiH, GershwinME. T cell immunity in autoimmune hepatitis. Autoimmun Rev4: 315–321, 2005.
41.
SannaV, GiacomoA, La CavaA, LechlerR, FontanaS, ZappacostaS, MatareseG.Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest11: 241–250, 2003.
42.
CohenP, YangG, YuX, SoukasAA, WolfishCS, FriedmanJM, LiC.Induction of leptin receptor expression in the liver by leptin and food deprivation. J Biol Chem280: 10034–10039, 2005.
43.
AleffiS, PetraiI, BertolaniC, ParolaM, ColombattoS, NovoE, VIzzuttiF, AnaniaFA, MilaniS, RomboutsK, LaffiG, PinzaniM, MarraF.Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology42: 1339–48, 2005.
44.
FaggioniR, Jones-CarsonJ, ReedDA, DinarelloCA, FeingoldKR, GrunfeldC, FantuzziG.Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor-a and IL-18. Proc Natl Acad Sci U S A97: 2367–2372, 2000.
45.
SiegmundB, Lear-KaulKC, FaggioniR, FantuzziG.Leptin deficiency, not obesity, protects mice from Con A–induced hepatitis. Eur J Immunol32: 552–560, 2002.
